Non-ribosomal peptides play a critical role in the clinic
as therapeutic
agents. To access more chemically diverse therapeutics, non-ribosomal
peptide synthetases (NRPSs) have been targeted for engineering through
combinatorial biosynthesis; however, this has been met with limited
success in part due to the lack of proper protein–protein interactions
between non-cognate proteins. Herein, we report our use of chemical
biology to enable X-ray crystallography, molecular dynamics (MD) simulations,
and biochemical studies to elucidate binding specificities between
peptidyl carrier proteins (PCPs) and adenylation (A) domains. Specifically,
we determined X-ray crystal structures of a type II PCP crosslinked
to its cognate A domain, PigG and PigI, and of PigG crosslinked to
a non-cognate PigI homologue, PltF. The crosslinked PCP-A domain structures
possess large protein–protein interfaces that predominantly
feature hydrophobic interactions, with specific electrostatic interactions
that orient the substrate for active site delivery. MD simulations
of the PCP-A domain complexes and unbound PCP structures provide a
dynamical evaluation of the transient interactions formed at PCP-A
domain interfaces, which confirm the previously hypothesized role
of a PCP loop as a crucial recognition element. Finally, we demonstrate
that the interfacial interactions at the PCP loop 1 region can be
modified to control PCP binding specificity through gain-of-function
mutations. This work suggests that loop conformational preferences
and dynamism account for improved shape complementary in the PCP-A
domain interactions. Ultimately, these studies show how crystallographic,
biochemical, and computational methods can be used to rationally re-engineer
NRPSs for non-cognate interactions.